{"title": "Margaret Rosenfeld, MD, MPH", "author": "Chelsea Bothell; WA", "url": "https://www.seattlechildrens.org/directory/margaret-rosenfeld/", "hostname": "seattlechildrens.org", "description": "Margaret Rosenfeld, MD, MPH, Professor and Associate Vice-Chair for Clinical Research, Department of Pediatrics", "sitename": "Seattle Children's Hospital", "date": "2017-09-13", "cleaned_text": "Margaret Rosenfeld, MD, 1995 Children's Title: Professor and Associate Vice-Chair for Clinical Research, Department of Pediatrics Research Center: [Center for Clinical and Translational Research](https://www.seattlechildrens.org/research/centers-programs/clinical-and-translational-research/) - Margaret Rosenfeld, MD, MPH, is attending physician at Seattle Children's Hospital, Professor in the Department of Pediatrics at the University of Washington School of Medicine and Adjunct Professor in the Department of Epidemiology at the University of Washington School of Public Health. She is Associate Vice Chair for Clinical Research in the Department of Pediatrics and Co-Director of the Center for Clinical and Translational Research at the Seattle Children's Research Institute. Her clinical interests focus on the diagnosis and management of respiratory illnesses in children of all ages, working closely with families. She serves as CF consultant to the Washington State Newborn Screening Program. Her research program focuses on NIH and foundation-sponsored multicenter observational and interventional studies in pediatric chronic lung diseases, including cystic fibrosis and primary ciliary dyskinesia. She also conducts research on mobile health tools for respiratory diseases including home spirometry. - Related Pages - Margaret Rosenfeld - - - We met with Dr. Rosenfeld to follow up after our toddler's recent admission for Reactive Airway Disease. She was warm, knowledgeable, and spent plenty of time with us answering our questions. She validated our concerns/fears and gave us good insight into his condition. We felt confidence in the plan of action after the appointment. We feel really grateful to have her as part of our son's medical team. - We first saw Dr. Rosenfeld when our child was very young, around 4 months old. We were seeing her to determine if our child had PCD. She was very caring, thourough, and was willing to sit and answer all our questions as long as we needed. She has continued caring for our child, who is now 2. We are so greatful to have such a knowledgable Doctor taking care of our child and helping us prevent future health problems and research this rare pulmonary disorder. We highly recommend her. Ellisa Alderson - - Award Name Award Description Awarded By Award Date SEATTLE TOP DOCTOR - 2022 Seattle Magazine 2022 Finalist, UW School of Medicine Mentoring Award 2016 School of Medicine Mentoring Award 2013 Finalist, UW School of Medicine Mentoring Award 2010 Physician Scientist Fellowship Award Glaxo Corporation 1993 Leroy Matthews Physician Scientist Award Cystic Fibrosis Foundation 1992 - 1998 - Manuscripts in Refereed Journals - Pope CE, Vo AT, Hayden HS, Weiss EJ, Durfey S, McNamara S, Ratjen A, Grogan B, Carter S, Nay L, Parsek MR, Singh PK, McKone EF, Aitken ML, Rosenfeld LRChanges in fecal microbiota with CFTR modulator therapy: - Beydon N, Gochicoa L, Jones MJ, Lands LC, Lombardi E, Rosenfeld M, Sly P, Weiner DJ, Yilmaz OPediatric lung function testing during a pandemic: An international perspective Paediatr Respir Rev, 2020 Oct 11 : 36106-108 Fink AK, Graff DR, Rosenfeld M, Saiman L. Palivizumab and Long-term Outcomes in Cystic Fibrosis.Palivizumab and Long-term Outcomes in Cystic Fibrosis Pediatrics, 2019 - Ratjen F, Davis SD, Stanojevic Kronmal RA, Hinckley Rosenfeld M, AK, Schechter Morgan cystic fibrosis. J Cyst Fibros, 2019 - Rosenfeld M, A, Regelmann WE, Sawicki GS, Southern KW, Chilvers Higgins M, S, Cooke J, Davies JC; KLIMB study groupAn open-label extension study of ivacaftor in children with CF and a CFTR gating mutation initiating treatment at age 2-5 years (KLIMB). J Cyst Fibros, 2019 - Davis SD, Rosenfeld M, Lee HS, Ferkol TW, Sagel SD, Dell SD, Milla C, Pittman JE, Shapiro AJ, Sullivan KM, Nykamp KR, Krischer JP, Zariwala MA, Knowles MR, Disorders of Mucociliary Clearance ConsortiumPrimary Ciliary Dyskinesia: Longitudinal Study of Lung Disease by Ultrastructure Defect and Genotype. Am J Respir Crit Care Med, 2018 - Chi DL, Rosenfeld M, Manci L, Chung WO, Presland RB, Sarvas E, Rothen M, Alkhateeb A, McNamara A, I, Milla C, Scott JAge-related heterogeneity in dental caries and associated risk factors in individuals with cystic fibrosis ages 6-20 years: A pilot study - Mayer-Hamblett N, Retsch-Bogart G, Kloster M, Accurso F, Rosenfeld M, Albers G, Black P, Brown P, Cairns A, Davis S, Graff G, Kerby G, Orenstein D, Buckingham R, Ramsey B, for the OPTIMIZE Study GroupAzithromycin for Early Pseudomonas Infection in Cystic Fibrosis: The Optimize Randomized Trial Annals of the American Thoracic Society, 2018 - Shapiro AJ, Davis SD, Polineni D, Manion M, Rosenfeld M, Dell SD, Chilvers MA, Ferkol TW, Zariwala MA, Sagel SD, Josephson L, Yilmaz O, Olivier KN, Milla C, Pittman JE, Daniels MLA, Jones MH, IA, Ware SM, Daniel SJ, Cooper ML, Nogee B, Primary Ciliary Dyskinesia. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med, 2018 : e24-e39 - Rosenfeld M, Wainwright CE, Higgins M, Wang LT, McKee C, Campbell D, Schneider J, Cunningham S, Davies JC, ARRIVAL study groupIvacaftor treatment in children 12 to <24 months old with cystic fibrosis and a CFTR gating mutation: results from the a phase 3 single-arm study Lancet Respir Med, 2018 : 30202-9 - Rosenfeld M, VanDevanter DR, Ren CL, Elkin EP, Pasta DJ, Konstan MW, Morgan WJDecline in Lung Function Does not Predict Future Decline in Lung Function in Cystic Fibrosis Patients Pediatr Pulmonol, 2018 - Ratjen F, Klingel M, Black P, Powers MR, Grasemann H, Solomon M, Sagel SD, Donaldson SH, Rowe SM, Rosenfeld MChanges in Lung Clearance Index in Preschool Cystic Fibrosis Patients Treated with Ivacaftor Am J Respir Crit Care Med, 2018 - Robinson PD, Latzin P, Ramsey KA, Stanojevic S, Aurora P, Davis SD, Gappa M, Hall GL, Horsley A, Jensen R, Lum S, Milla C, Nielsen KG, Pittman JE, Rosenfeld M, Singer F, Subbarao P, Gustafsson PM, Ratjen FATS Assembly on Pediatrics. Preschool Multiple-Breath Washout Testing. An Official American Thoracic Society Technical Statement Am J Respir Crit Care Med, 2018 - Cogen JD, Onchiri F, Gibson RL, Rosenfeld MChronic Azithromycin Risk of Treatment-Emergent Respiratory Pathogens Ann Am Thorac Soc, 2018 - Edwards TC, Emerson J, Genatossio A, McNamara S, Onchiri F, Goss C, Patrick DL, Rosenfeld MInitial Development and Pilot Testing of Observer-Reported Outcomes (ObsROs) for Children with Cystic Fibrosis D'Agostino E, Strassle C, Schechter MS, Rosenfeld MRisk Factors for Gaps in Care during Transfer from Pediatric to Adult Cystic Fibrosis Programs in the United States. Ann Am Thorac Soc, 2017 - Culver B, Graham B, Coates A, Wanger J, Berry C, Clarke P, Hallstrand T, Hankinson J, Kaminsky D, MacIntyre N, McCormack M, Rosenfeld M, Stanojevic S, Weiner DRecommendations for a Standardized Pulmonary Function Report - An ATS Technical Statement Am J Resp Crit Care Med , 2017 : 1463-1472 - Heltshe SL, Khan U, Beckett V, Baines A, Emerson J, Sanders DB, Gibson RL, Morgan W, Rosenfeld MLongitudinal development of initial, chronic and mucoid Pseudomonas aeruginosa infection young Fibros, 2017 - Ratjen F, Hug G, S, Huang X, Stanojevic S, Milla CE, Robinson PD, Waltz D, Davies Rosenfeld MEfficacy and safety of lumacaftor in aged homozygous F508del-CFTR: : 557-567 - Psoter KJ, DeRoos AJ, Wakefield J, Mayer J, Rosenfeld MAir pollution exposure is associated with MRSA acquisition in young U.S. children with cystic fibrosis BMC Med, 2017 : 106 Roos AJ, Wakefield J, Mayer JD, Rosenfeld MSeasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosis BMC Infect Dis, 2017 : 411 - Otjen JP, Swanson JO, Oron A, DiBlasi RM, Swortzel T, Van Well J, Gommers E, Rosenfeld MSpirometry-assisted HRCT in children: Is it worth RL, Hoffman L, M, T, MCharacterization Cystic Fibrosis Pulmonary Exacerbations Pediatrics, SE, Accurso F, Derichs N, Howenstine M, McColley SA, Rock M, Rosenfeld M, Sermet-Gaudelus I, Southern KW, Marshall BC, Sosnay PRDiagnosis of Cystic the Foundation J Pediatr, 2017 - Ong T, Schechter M, Yang J, Peng L, Emerson J, Gibson RL, Morgan W, Rosenfeld M for the EPIC Study GroupSocioeconomic Status and Environmental Tobacco Smoke Impact on Lung Outcomes in Cystic Fibrosis Pediatrics, 2017 : 139(2) - Farrell PM, White Howenstine MS, Munck A, Parad RB, Rosenfeld M, Sommerburg Accurso FJ, Davies JC, Rock MJ, Sanders DB, M, 2017 - Leigh MW, Ferkol TW, Davis SD, Lee HS, Rosenfeld M, Dell SD, Sagel SD, Milla C, Olivier KN, Sullivan KM, Zariwala Krischer J, Hazucha MJ, MRClinical Features and Associated Likelihood of Primary Ciliary Dyskinesia in Children and Adolescents. Ann Am Thorac Soc, 2016 : 1305-13 - Lahiri T, Hempstead SE, Brady C, Cannon C, Clark K, Condren ME, Guill MF, Guillerman with Cystic Fibrosis Journal of Pediatrics, 2016 : 137(4) - Leigh MW, Ferkol TW, Davis SD, Lai HS, Rosenfeld M, Dell SD, Sagel SD, Milla C, Olivier KN, Sullivan Krischer J, Hazucha M, MClinical Features and Associated Likelihood of Primary Ciliary Dyskinesia in Children and Adolescents Ann Am Thoracic Society, 2016 - Shapiro AJ, Zariwala MA, Ferkol T, Davis SD, Sagel SD, Dell SD. Rosenfeld M, Olivier KN, Milla C, Daniel SJ, Kimple AJ, Manion M, Knowles MR, Leigh MWDiagnosis, Evaluation, and Treatment of Primary Ciliary Dyskinesia:PCD Foundation Consensus Recommendations Based on State of the Art Review Pediatric Pediatr Pulmonol, 2016 : 115-32 - Davies, JC, Cunningham S, WT, Lapey A, Regelmann WE, Sawicki GW, Southern KW, Robertson S, Green Y, Cooke J, Rosenfeld MAn Open-Label Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Ivacaftor in Patients Aged 2 to 5 Years with Cystic Fibrosis from a CFTR Gating Mutation: The KIWI Study Respir Med, 2016 107-15 - Peterson-Carmichael S, Seddon P, Cheifetz I, Frerichs I, J, Ranganathan SAn Official ATS/ERS Workshop Report: Evaluation of Respiratory Mechanics and Function in the Pediatric and Neonatal Intensive Care Units Ann Am Thorac Soc, 2016 : S1-S11 - Davis SD, function tests as endpoints in the ISIS multicenter clinical trial Psoter KJ, De AJ, Wakefield J, Mayer JD, Bryan M, Rosenfeld MAssociation of meteorologic and geographic factors and risk of initial Pseudomonas aeruginosa acquisition in young children with cystic fibrosis Association of meteorologic and geographic factors and risk of initial Pseudomonas aeruginosa acquisition in young children with cystic fibrosis, 2015 : 1-9 - Sanders DB, Fink N, Schechter MS, Sawicki GS, Rosenfeld WJEarly Life Growth Trajectories in Cystic Fibrosis are Associated with Pulmonary Function at Age 6 Years J Pediatr, 2015 - Sanders DB, Emerson J, Ren C, Schechter MS, Gibson RL, Morgan W, Rosenfeld M for the EPIC Study GroupEarly childhood risk factors for decreased FEV1 at age 6-7 years in young children with cystic fibrosis Ann Am Thorac Soc, 2015 : 1170-6 - Ren C, Fink A, Petren K, Borowitz D, McColley S, Rosenfeld M, Sanders D, Marshall BOutcomes of Infants with Indeterminate Diagnosis Detected by Cystic Fibrosis Newborn Screening Pediatrics, 2015 : 2014-3698 - Subbarao P, Milla C, Aurora P, Davies J, Davis S, Hall G, Heltshe S, Latzin P, Linblad A, Pittman J, Robinson P, Rosenfeld M, Singer F, Starner T, Ratjen F, Morgan WMultiple Breath Washout as a Lung Function Test in Cystic Fibrosis: Ready for Prime Time? Ann Am Thorac Soc, 2015 : 932-9 - Cogen J, Sanders DB, Ren C, Schechter M, Emerson J, Gibson R, Morgan W, Rosenfeld M for the EPIC Study GroupRisk factors for lung function decline in a large cohort of young cystic fibrosis patients Pediatr Pulmonol, GS, Rasouliyan L, DR, Rosenfeld M, Pasta D, Morgan W, Konstan MWAntibiotic treatment of pulmonary exacerbations: a comparison by care site Pediatr Pulmonol, 2015 : 431-40 - Psoter KJ, De Mayer JD, Kaufman JD, Wakefield J, Rosenfeld MFine particular matter exposure and initial Pseudomonas aeruginosa acquisition in cystic fibrosis Ann Am Thorac Soc, 2015 : 385-91 - Davis SD, Ferkol TW, Rosenfeld M, Lee HS, Dell SD, Sagel SD, Milla C, Zariwala MA, Pittman JE, Shapiro JL, JP, Hazucha MJ, Cooper ML, Knowles MR, primary ciliary genotype and ultrastructural phenotype Am J Care Med, 2015 : 316- 24 - Zemanick ET, Emerson J, Thompson V, McNamara Sh, Morgan W, Gibson RL, Rosenfeld M for the EPIC Study GroupClinical outcomes after initial Pseudomonas acquisition in cystic fibrosis Pediatric Pulmonology, 2015 : 42-8 - Mogayzel PJ Jr, Naureckas ET, Robinson KA, Brady C, Guill M, Lahiri T, Lubsch L, Matsui J, Oermann F, RH, Hazle L, Sabadosa K, Marshall BCCystic Fibrosis Foundation Pulmonary Clinical Practice Guidelines Committee. Cystic Fibrosis Foundation pulmonary guideline. pharmacologic approaches to prevention and eradication of initial Pseudomonas aeruginosa infection. Ann Am Thorac Soc, 2014 : 1640-50 - Alpern AN, Brumback F, Rosenfeld the Parent Cystic Fibrosis Questionnaire-Revised infants and young Fibrosis Journal of Cystic Fibrosis DJ, Houston CE, Kulasekara BR, Armbruster CR, Burns JL, Retsch-Bogart G, Rosenfeld M, Gibson RL, Miller SI, Khan U, Hoffman LRPseudomonas aeruginosa phenotypes associated with eradication failure in children with cystic fibrosis Clin Infect Dis , 2014 : 624-31 - Daines C, VanDeVanter D, Khan U, Emerson J, Heltshe S, McNamara S, Anstead M, Langkamp M, Doring G, Ratjen F, Ramsey B, Gibson RL, Morgan W, Rosenfeld M; EPIC InvestigatorsSerology as a diagnostic tool for predicting initial Pseudomonas aeruginosa acquisition in children with cystic , 2014 : Ramsey BW, HD, Retsch-Bogart GZ, Morgan W, Wolter DJ, Pope CE, Houston LS, Kulasekara BR, Khan U, Burns JL,Milller SI, Hoffman LRPseudomonas aeruginosa in vitro phenotypes distinguish cystic fibrosis infection stages and outcomes Am J Respir Crit Care Med, 2014 : 289-97 - Psoter KJ, Rosenfeld M, De Roos AJ, Mayer JD, Wakefield JDifferential Geographical Risk of Initial Pseudomonas aeruginosa Acquisition in Young U.S. Children with Cystic Fibrosis American Journal of Epidemiology , 2014 June : 1503-13 - Stanojevic, S., Stocks, J., Bountziouka, V,. Aurora, P., Kirkby, J., Bourke, S., Carr, S.B., Gunn, E., Prasad, A., Rosenfeld, M., Bilton, DThe Impact of switching to the new Global Lung Function Initiative Equations on Spirometry Results in the UK CF Registry Journal of Cystic Fibrosis, 2014 May : 319-27 - Brumback LC, Baines A, Ratjen F, Davis SD, Daniel SL, AL, Rosenfeld M; for the ISIS Study GroupPulmonary exacerbations Hazucha Shapiro AJ, Lavange LM, Horton BJ, Qaqish B, Carson JL, Davis SD, Ferkol TW, Atkinson JJ, Olivier KN, Sagel SD, Rosenfeld M, C, Lee HS, Krischer J, Zariwala MA, Knowles Genetic Disorders of Mucociliary Clearance ConsortiumStandardizing Nasal Nitric Oxide Measurement as a Test for Primary Ciliary Dyskinesia 12406843 Ann Am Thorac Soc, 2013 Dec. : 574-81 Other Publications - Davis CS, Faino AV, Onchiri F, Gibson RL, Merjaneh L, Ramsey BW, Rosenfeld M, JDSystemic Management of Pediatric Cystic Fibrosis Pulmonary Exacerbations. 36044723 Annals of the American Thoracic Society, 2023 Jan. : 20(1)75-82 - Sagel SD, Kupfer O, Wagner BD, Davis SD, Dell SD, Ferkol TW, Hoppe JE, Rosenfeld M, Sullivan KM, Tiddens HAWM, Knowles MR, Leigh MWAirway Inflammation in Children with Primary Ciliary Dyskinesia. 35984413 Annals of the American Thoracic Society, 2023 : 20(1)67-74 PMCID:PMC9819265 - Spurr R, Ng E, Onchiri FM, Rapha Nakatumba-Nabende J, M, Najjingo I, Stout JW, Nantanda R, Ellington LEPerformance and usability of a new mobile application for measuring respiratory rate in young children with acute lower respiratory infections. 35996862 Pediatric pulmonology, 2022 Dec. : 57(12)3009-3016 - Kinghorn B, Rosenfeld M, Sullivan E, Onchiri F, Ferkol TW, Sagel SD, Dell SD, Milla C, Shapiro AJ, Sullivan KM, Zariwala MA, Pittman F, Tiddens HAWM, M, MR, SD, Leigh MW, Genetic Disorders of Mucociliary Clearance ConsortiumAirway Disease in Children with Primary Ciliary Dyskinesia: Impact of Ciliary Ultrastructure Defect and Genotype. 36442147 Annals of the Society, 2022 Nov 28 - Rayment JH, Asfour F, Rosenfeld M, Higgins M, Liu L, Mascia M, Paz-Diaz H, Tian S, Zahigian R, McColley SAA Phase 3, Open-Label Study of Lumacaftor/Ivacaftor in Children 1 to Less Than 2 Years of Age with Cystic Fibrosis Homozygous for F508del-CFTR. 35771568 American journal of respiratory and critical care medicine, 2022 Nov 15 : 206(10)1239-1247 PMCID:PMC9746849 - Rayment JH, Asfour F, Rosenfeld M, Higgins M, Liu L, Mascia M, Paz-Diaz H, Tian S, Zahigian R, McColley SAA Phase 3, Open-Label Study of Lumacaftor/Ivacaftor in Children 1 to Less Than 2 Years of Age with Cystic Fibrosis Homozygous for F508del-CFTR. 35771568 American journal of respiratory and critical care medicine, 2022 Nov 15 : 206(10)1239-1247 PMCID:PMC9746849 - Barber AT, Shapiro AJ, Davis SD, Ferkol TW, Atkinson JJ, Sagel SD, Dell SD, Olivier KN, Milla CE, Rosenfeld M, Li L, Lin FC, KM, Capps NA, Zariwala MA, Knowles MR, Leigh MW, Genetic Disorders of Mucociliary Clearance Consortium (GDMCC)Laterality Defects in Primary Ciliary Dyskinesia: Relationship to Ultrastructural Defect or Genotype. 36342963 Annals of the American Thoracic Society, 2022 Nov 7 - Wee WB, Leigh MW, Davis SD, Rosenfeld M, Sullivan KM, Sawras MG, Ferkol TW, Knowles MR, Milla C, MA, Pullenayegum E, Dell SDAssociation of Neonatal Hospital Length of Stay with Lung Function in Primary Ciliary Dyskinesia. 35657736 Annals of the American 19(11)1865-1870 PMCID:PMC9667809 - Schwarzenberg M, C, Gelfond D, Narkewicz MR, Nichols DP, Heltshe SL, Donaldson SH, Frederick CA, Kelly A, Pittman JE, Ratjen F, Rosenfeld M, Sagel SD, Solomon GM, Stalvey MS, Clancy JP, Rowe SM, Freedman SD, Promise Study GroupElexacaftor/tezacaftor/ivacaftor and gastrointestinal outcomes in fibrosis: Report of promise-GI. 36280527 Journal of cystic fibrosis official journal of the European Cystic Fibrosis Society, 2022 Oct 21 - Aksit AV, Pagel K, Pugh E, Stilp AM, Sun Q, Blue EE, Wright FA, Zhou YH, Bamshad MJ, Gibson obstruction cystic fibrosis. 36206743 American journal of human genetics, 2022 Oct 6 : 109(10)1894-1908 PMCID:PMC9606479 - Rosenfeld M, Ostrenga J, Cromwell EA, Magaret A, Szczesniak R, Fink A, Schechter MS, Faro A, Ren CL, Morgan W, Sanders DBReal-world Associations of US Cystic Fibrosis Newborn Screening Programs With Nutritional and Pulmonary Outcomes. 35913705 JAMA pediatrics, 2022 Oct 1 : 176(10)990-999 PMCID:PMC9344390 J, Emond MJ, Spangenberg A, Stern Vasquez MM, Blue EE, Buckingham KJ, Sherrill DL, Halonen M, WJ, Guerra SClub cell with cystic fibrosis. 35367162 Journal of cystic fibrosis : official journal European Cystic Fibrosis Society, 2022 Sept. : RL, Juarez-Colunga E, Zemanick ET, Rosenfeld M, Wagner BDApplication of gap time analysis with flexible hazards to pulmonary exacerbations in the EPIC observational study. 35434808 Biometrical Rosenfeld M, Kronman MPClinical Outcomes of Antipseudomonal versus Other among Children with Cystic Fibrosis without Pseudomonas aeruginosa. 35289740 Annals of the American 2022 Aug. : 19(8)1320-1327 - Rosenfeld M, Ratjen FCOMBATing airway inflammation in infants with cystic fibrosis. 35662407 The Lancet. Respiratory medicine, 2022 Aug. : 10(8)727-729 - Kingston H, Stilp AM, Gordon W, Broome J, Gogarten SM, Ling H, Barnard J, Dugan-Perez S, Ellinor PT, Gabriel S, Germer S, Gibbs RA, Gupta N, Rice K, MC, Fibrosis SM, Cutting Knowles MR, Zhou YH, M, Gibson RL, Bamshad M, Fohner A, Blue EEAccounting for population structure genetic studies of cystic fibrosis. 35647563 HGG advances, Stanojevic S, Kaminsky DA, Miller MR, Thompson B, Aliverti A, Barjaktarevic I, Cooper BG, Swenson ERERS/ATS technical standard on interpretive strategies for routine lung function tests. 34949706 The European respiratory journal, 2022 July : 60(1) - Tiddens HAWM, Chen Y, Andrinopoulou ER, Davis SD, M, Ratjen F, Kronmal RA, Stukovsky KD, Dasiewicz GroupThe effect of inhaled hypertonic saline on lung structure in children aged fibrosis (SHIP-CT): a multicentre, medicine, July : 10(7)669-678 - Nichols DP, Paynter AC, Heltshe SL, Donaldson SH, Frederick CA, Freedman SD, Gelfond D, Hoffman LR, Kelly A, Narkewicz MR, Pittman JE, F, Rosenfeld Sagel PK, JM, Rowe SM, PROMISE groupClinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis: A Clinical Trial. 34784492 American journal of respiratory and critical care medicine, 2022 Mar 1 : 205(5)529-539 MAssociation of Intensity of Antipseudomonal Antibiotic Therapy With Risk of Treatment-Emergent Organisms in Children With Cystic Fibrosis and Newly Acquired Pseudomonas Aeruginosa. 33693586 Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021 Sep 15 : 73(6)987-993 - Rosenfeld M, Faino AV, F, Aksit MA, cystic fibrosis. 34393091 Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2021 Aug 12 - Graustein AD, Berrington KJ, Outcomes in Cystic Fibrosis. 33848452 American journal of respiratory cell and molecular biology, 2021 Aug. : 65(2)157-166 PMCID:PMC8399576 - Ellington LE, Najjingo I, Rosenfeld M, Stout Farquhar SA, Vashistha A, Nekesa B, Namiya Z, Kruse AJ, Anderson R, Nantanda RHealth workers' perspectives of a mobile health tool to improve diagnosis and management of paediatric acute respiratory illnesses in Uganda: a qualitative study. 34281930 BMJ open, M, Gibson RLAssociation Between Number of Intravenous Antipseudomonal Antibiotics and Clinical Outcomes of Pediatric Cystic Fibrosis Pulmonary Exacerbations. 34100912 Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021 Jun 8 - Merjaneh L, Toprak D, McNamara S, Nay L, Sullivan E, Rosenfeld MAcute hyperglycaemia in cystic fibrosis pulmonary : 4(2)e00208 PMCID:PMC8029509 - Nichols DP, Donaldson SH, Frederick CA, Freedman SD, Gelfond D, Hoffman LR, Kelly A, Narkewicz MR, Pittman JE, F, Sagel Rosenfeld JM, Clancy JP, Rowe SMPROMISE: Working with the CF community to understand emerging clinical and research needs for those treated with highly effective CFTR modulator therapy. 33619012 Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2021 March : 20(2)205-212 - Banks JT, Rosenfeld M, Mancl L, Chi DLSurvey and electronic health record-based medication use agreement in children with cystic fibrosis: A retrospective cross-sectional study. 32936971 International journal of paediatric dentistry, 2021 March : Davies JC, Wainwright Sawicki Higgins MN, Campbell D, Harris C, Panorchan P, Haseltine E, Tian S, Rosenfeld MIvacaftor in Infants Aged 4 to <12 Months with Cystic Fibrosis and a Gating Mutation. Results of a Two-Part Phase 3 Clinical Trial. 33023304 American journal of respiratory and critical care medicine, 2021 Mar 1 : 203(5)585-593 PMCID:PMC7924576 - Taylor JB, Oermann CM, Deterding Davis SD, Piccione J, Moore PE, Kupfer O, Santiago MT, Rosenfeld M, Ingram DG, Ross K, DeBoer EMInnovating and adapting in pediatric pulmonology and sleep medicine during the COVID-19 pandemic: ATS pediatric assembly web committee consensus statement for initial COVID-19 virtual response. 33300286 Pediatric pulmonology, 2021 Feb. : Rosenfeld M, Nichols DPEffect of Azithromycin Tobramycin Use on Cystic Fibrosis Pulmonary Exacerbation Treatment. 32810412 Annals the MP, M, Nichols DP, Rosenfeld M, VanDevanter DR, Gibson RLAssociation of Inhaled Antibiotics in Addition to Standard Intravenous Therapy and Outcomes of Pediatric Inpatient Pulmonary Exacerbations. 32726564 Annals of the American Thoracic Society, 2020 Dec. : 17(12)1590-1598 PMCID:PMC7924435 - Hoppe JE, Hinds DM, Colborg A, WJ, Rosenfeld M, Zemanick ET, Sanders DBOral antibiotic prescribing patterns for treatment of pulmonary exacerbations in two large pediatric CF centers. 32970375 Pediatric pulmonology, 2020 Dec. : 55(12)3400-3406 - Wilson KC, N, Mandel J, McCarthy K, McCormack M, Patil SP, Rosenfeld M, Senitko M, Sethi S, Swenson ER, Stanojevic S, Teodorescu M, Weiner DJ, Wiener RS, Powell CARestoring Pulmonary and Sleep Services as the COVID-19 Pandemic Lessens. From an Association of Pulmonary, Critical Care, and Sleep Division Directors and American Thoracic Society-coordinated Task Force. 32663071 Annals of the American Thoracic Society, 2020 Nov. : 17(11)1343-1351 PMCID:PMC7640724 - Rosenfeld cystic fibrosis. 32997797 The Cochrane of systematic reviews, 2020 Sep 30 : 9CD001912 PMCID:PMC8430459 - Kinghorn B, McNamara S, Genatossio A, Sullivan E, Siegel M, Bauer I, Clem C, Johnson RC, Davis M, Griffiths A, Wheeler W, Johnson K, Davis SD, Leigh MW, Rosenfeld M, Pittman JComparison of Multiple Breath Washout and in Children with Primary Ciliary Dyskinesia and Cystic Fibrosis and Healthy Controls. 32603187 Annals of the American Thoracic Society, 2020 Sept. : 17(9)1085-1093 PMCID:PMC7462330 - Sanders DB, fibrosis. 31257102 Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2020 May : 19(3)407-414 PMCID:PMC6940539 - Toprak D, Nay L, McNamara S, Rosenberg AR, Rosenfeld M, Yi-Frazier JPResilience in adolescents and young adults with cystic fibrosis: A pilot feasibility study of the promoting resilience in stress management\u00c2 intervention. 31794160 Pediatric pulmonology, 2020 March : 55(3)638-645 - Juarez-Colunga E, Rosenfeld M, Zemanick ET, Wagner BApplication of multiple event analysis as an alternative approach to studying pulmonary exacerbations as an outcome measure. 30642785 Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2020 Jan. : 19(1)114-118 PMCID:PMC8127951 - Mainz JG, DH, Fridman M, Sawicki GS, Rosenfeld Pulmonary Exacerbations in Patients with Cystic Fibrosis. 31761140 The Journal of pediatrics, 2019 Dec. : 215164-171.e2 - Toprak D, Davis C, Rosenfeld MTreating the Airway Consequences of Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction. 31659732 Seminars in respiratory and critical care medicine, 2019 Dec. : 40(6)751-761 - Rosenfeld M, Cunningham S, Harris WT, Lapey A, Regelmann WE, Sawicki GS, Southern KW, Chilvers M, Higgins M, Tian S, Cooke J, Davies JC, KLIMB study group.An open-label extension study of ivacaftor in children with CF and a CFTR gating mutation initiating treatment at age 2-5\u00e2\u20ac\u00afyears (KLIMB). 31053538 Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2019 Nov. : 18(6)838-843 PMCID:PMC6821553 - Stanojevic S, Swanney MP, Thompson BRStandardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement. 31613151 American journal of respiratory and critical care medicine, 2019 Oct 15 : 200(8)e70-e88 PMCID:PMC6794117 - Ratjen F, Davis SD, Stanojevic S, Kronmal RA, Hinckley Stukovsky Jorgensen N, Rosenfeld M, SHIP double-blind, placebo-controlled Lancet. Respiratory medicine, 2019 Sept. : 7(9)802-809 - Hannah WB, DeBrosse S, Kinghorn B, Strausbaugh S, Aitken ML, Rosenfeld M, Wolf WE, dyskinesia. 31373179 Molecular genetics & genomic medicine, 2019 - Kinghorn B, AM, O'Leary RA, Karr CJ, Rosenfeld M, Best LGSocioeconomic and Environmental Risk Factors for Pediatric Asthma in an American Indian Community. 31103883 Academic pediatrics, 2019 Aug. : 19(6)631-637 - Fink AK, Graff G, Byington CL, Loeffler DR, Long-term in Cystic Fibrosis. 31239289 Pediatrics, 2019 July : 144(1) - Hopkinson NS, Hart N, Jenkins G, Rosenfeld M, Smyth AR, Wilkinson AJK, Kaminski NClimate change and lung health: presidential failure, professional responsibility. 31010935 Thorax, 2019 July - Szczesniak RD, Cogen JD, Rosenfeld MAssociating antimicrobial susceptibility testing with clinical outcomes in cystic fibrosis: More rigor and less frequency? 30824378 Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2019 March : 18(2)159-160 PMCID:PMC7020339 - Davis SD, Rosenfeld M, Lee HS, Ferkol TW, Sagel SD, Dell SD, Milla C, Pittman JE, Shapiro AJ, Sullivan KM, Nykamp MA, Knowles MR, Leigh Dyskinesia: Longitudinal Study of Lung Disease by Ultrastructure Defect and Genotype. 30067075 American journal of respiratory and critical care medicine, 2019 Jan 15 : 199(2)190-198 PMCID:PMC6353004 - Chi DL, Rosenfeld M, Mancl L, Chung WO, Presland RB, Sarvas E, Rothen M, Alkhateeb A, McNamara A, I, Milla C, Scott JAge-related heterogeneity in dental caries and associated risk factors in individuals with cystic fibrosis ages 6-20 years: A pilot study. 30005828 Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2018 Nov. : 17(6)747-759 PMCID:PMC6589399 - Mayer-Hamblett Retsch-Bogart G, Kloster M, Accurso F, Rosenfeld M, Albers G, Black P, Brown P, Cairns A, Davis SD, Graff GR, Kerby GS, Orenstein D, Buckingham R, Ramsey BW, Study Group.Azithromycin for Early Pseudomonas Infection in Cystic Fibrosis. The OPTIMIZE Randomized Trial. 29890086 American journal of respiratory and critical care medicine, 2018 Nov 1 : 198(9)1177-1187 PMCID:PMC6221579 - Rosenthal DA, Nassir R, Vickers Li C, U, Jarvik GP, NHLBI GO Exome Sequencing Project.Rare loss of function variants in candidate genes and risk of colorectal cancer. 30267214 Human genetics, 2018 Oct. : 137(10)795-806 PMCID:PMC6283057 - Ratjen F, Klingel M, Black P, Powers MR, Grasemann H, Solomon M, Sagel SD, Donaldson SH, Rowe SM, Rosenfeld MChanges in Lung Clearance Index in Preschool-aged Patients with Cystic Fibrosis Treated with Ivacaftor (GOAL): A Clinical Trial. 29614238 American journal of respiratory and critical care medicine, 2018 Aug 15 : 198(4)526-528 PMCID:PMC6835087 - Culver BH, Graham BL, MacIntyre NR, McCormack M, Kaminsky DA, Coates AL, Weiner DJ, Rosenfeld M, Wanger J, ATS Committee on Proficiency Standards for Pulmonary Function Laboratories.Reply to Johnson: Improve Pulmonary Function Test Reporting. 29533673 American journal of respiratory and critical care medicine, 2018 Jul 1 : 198(1)138-139 - Rosenfeld M, Wainwright CE, Higgins M, Wang LT, McKee C, Campbell D, Tian S, Schneider J, Cunningham S, Davies JC, ARRIVAL study group.Ivacaftor treatment of cystic fibrosis in children aged 12 to <24 months and with a CFTR gating mutation (ARRIVAL): a phase 3 single-arm study. 29886024 The Lancet. Respiratory medicine, 2018 July : 6(7)545-553 PMCID:PMC6626762 - Shapiro AJ, Davis SD, Polineni D, Manion M, Rosenfeld M, Dell SD, Chilvers MA, Ferkol TW, Zariwala MA, Sagel SD, Josephson L, Yilmaz O, Olivier KN, Milla C, Pittman JE, Daniels MLA, Jones MH, IA, Ware SM, Daniel SJ, Cooper ML, Nogee B, MR, Leigh MW, Lavergne V, Thoracic Society Assembly on Pediatrics.Diagnosis of Primary Ciliary Dyskinesia. An Official American Thoracic Society Clinical Practice Guideline. 29905515 American journal of respiratory and critical care medicine, 2018 Jun 15 : 197(12)e24-e39 PMCID:PMC6006411 - Cogen JD, Onchiri F, Rosenfeld MChronic Azithromycin Risk Treatment-Emergent Respiratory Pathogens. 29474110 Annals of the American Thoracic Society, 2018 June : 15(6)702-709 PMCID:PMC6850787 - Robinson PD, Latzin P, Ramsey KA, Stanojevic S, Aurora P, Davis SD, Gappa M, Hall GL, Horsley A, Jensen R, Lum S, Milla C, Nielsen KG, Pittman JE, Rosenfeld M, Singer F, Subbarao P, Gustafsson PM, Ratjen F, ATS Assembly on Pediatrics.Preschool Multiple-Breath Washout Testing. An Official American Thoracic Society Technical Statement. 29493315 American journal of respiratory and critical care medicine, 2018 Mar 1 : 197(5)e1-e19 - Rosenfeld M, Ostrowski LE, Zariwala MAPrimary ciliary dyskinesia: keep it Cystic Fibrosis Pulmonary Exacerbations: In the Hospital with a Physician or at Home under Your Own Supervision? 29388818 Annals of the American Thoracic Society, 2018 Feb. : 15(2)169-170 - Sawicki GS, Ostrenga Petren K, E, Strassle C, Schechter MS, Rosenfeld MRisk Factors for Gaps in Care during Transfer from Pediatric to Adult Cystic Fibrosis Programs in the United States. 29220199 Annals of the American Thoracic Society, 2018 Feb. : 15(2)234-240 - Hurley MN, Fogarty A, McKeever TM, Goss CH, Rosenfeld M, Smyth AREarly Respiratory Bacterial Detection and Antistaphylococcal Antibiotic Prophylaxis in Young Children with Cystic Fibrosis. 29035090 Annals of the American Thoracic Society, 2018 Jan. : 15(1)42-48 PMCID:PMC5822417 - Otjen JP, Swanson JO, Oron A, DiBlasi RM, Swortzel T, van Well JAM, Gommers EAE, Rosenfeld MSpirometry-Assisted High Resolution Chest Computed Tomography in Children: Is it Worth the Effort? 28552547 Current problems in diagnostic radiology, 2018 Jan. : 47(1)14-18 PMCID:PMC6628913 - Culver BH, Graham M, Stanojevic S, Weiner DJ, ATS Committee on Proficiency Standards for Pulmonary Function Laboratories.Recommendations for a Standardized Pulmonary Function Report. An Official American Thoracic Society Technical Statement. 29192835 American journal of respiratory and critical care medicine, 2017 Dec 1 : 196(11)1463-1472 - Psoter KJ, De Roos AJ, Wakefield J, Mayer JD, Rosenfeld MAir pollution exposure is associated with MRSA acquisition in young U.S. children with cystic fibrosis. 28750627 BMC pulmonary medicine, 2017 Jul PMCID:PMC5530959 - Ratjen F, Hug C, Marigowda G, Tian S, Huang X, Stanojevic S, Milla CE, Robinson PD, Waltz D, Davies JC, VX14-809-109 investigator group.Efficacy and safety of lumacaftor and ivacaftor in aged F508del-CFTR: a randomised, phase 3 28606620 The Lancet. Respiratory medicine, 2017 July : 5(7)557-567 - Shapiro AJ, Josephson M, Rosenfeld M, Yilmaz O, Davis SD, Polineni D, Guadagno E, Leigh MW, Lavergne VAccuracy of Nasal Nitric Oxide Measurement as a Diagnostic Test for Primary Ciliary Dyskinesia. A Systematic Review and Meta-analysis. 28481653 Annals of the American Thoracic Society, 14(7)1184-1196 PMCID:PMC6137897 - Psoter Roos AJ, Wakefield J, Mayer JD, Rosenfeld MSeasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosis. 28599639 BMC 2017 needle? 28416146 Journal of fibrosis : official journal of the European Cystic Fibrosis Society, 2017 May : 16(3)309-310 - Pittman J, Rosenfeld MElementary, My Dear Watson! The Accumulating Evidence for the Lung Clearance Index in Monitoring Early Cystic Fibrosis Lung Disease. 28459345 American journal of respiratory and critical care medicine, 2017 May 1 : 195(9)1131-1132 - Smyth AR, antibiotics for 28417451 The Cochrane 4CD001912 PMCID:PMC6478147 - Milla CE, Ratjen F, Marigowda G, Liu F, Waltz D, Rosenfeld M, VX13-809-011 Part B Investigator Group *.Lumacaftor/Ivacaftor in Patients Aged 6-11 Years with Cystic Fibrosis and Homozygous for F508del-CFTR. 27805836 American journal of respiratory and critical care medicine, 2017 Apr 1 : 195(7)912-920 PMCID:PMC5440888 - Hopkinson NS, Hart N, Jenkins G, Kaminski N, Rosenfeld M, Smyth A, Wilkinson AClimate change and lung health: the challenge for a new president. 28104829 Thorax, 2017 April : 72(4)295-296 - Farrell Hempstead SE, Accurso F, Derichs N, Howenstine M, McColley SA, Rock M, Rosenfeld M, Sermet-Gaudelus I, Southern KW, Marshall BC, Sosnay PRDiagnosis of Consensus Guidelines from the Cystic Fibrosis Foundation. 28129811 The Journal of pediatrics, 2017 Feb. : 181SS4-S15.e1 - Farrell PM, White TB, Howenstine MS, Munck A, Parad RB, Rosenfeld M, Sommerburg Accurso FJ, Davies JC, Rock MJ, Sanders DB, M, of Cystic Fibrosis in Screened Populations. 28129810 The pediatrics, 2017 Feb. : 181SS33-S44.e2 JD, Oron AP, PMCID:PMC5472380 - Ong T, Schechter M, Yang J, Peng L, Emerson J, Gibson RL, Morgan W, Rosenfeld M, EPIC Study Group.Socioeconomic Status, Smoke Exposure, and Health Outcomes in Young Children With Cystic Fibrosis. 28093464 Pediatrics, 2017 Feb. : 139(2) PMCID:PMC5260155 - Leigh MW, Ferkol TW, Davis SD, Lee HS, Rosenfeld M, Dell SD, Sagel SD, Milla C, Olivier KN, Sullivan KM, Zariwala Krischer J, Hazucha MJ, MRClinical Features and Associated of Primary Ciliary Dyskinesia in Children and Adolescents. 27070726 Annals of the American Thoracic Society, 2016 Aug. : 13(8)1305-13 PMCID:PMC5021075 - Rosenfeld M, Sontag MK, Ren CLCystic Fibrosis Diagnosis and Newborn Screening. 27469178 Pediatric clinics of North America, 2016 Aug. : 63(4)599-615 - Davis SD, Ratjen ISIS Study lung function tests as endpoints in the ISIS multicenter trial in cystic fibrosis. 26547590 Journal of fibrosis : official journal of the European Cystic Fibrosis Society, 2016 May : 15(3)386-91 PMCID:PMC4854797 - Lahiri T, Hempstead SE, Brady C, Cannon MF, Guillerman RP, Leone Tompkins CL, ET, Davis Foundation for Preschoolers With Cystic Fibrosis. 27009033 Pediatrics, 2016 April : 137(4) - Davies JC, Cunningham S, Harris WT, Lapey A, Regelmann WE, Sawicki GS, Southern KW, Robertson S, Green Y, Cooke J, Rosenfeld M, KIWI Study Group.Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients an open-label, single-arm study. 26803277 The Lancet. Respiratory medicine, 2016 Feb. : 4(2)107-15 PMCID:PMC6734927 - Shapiro AJ, Zariwala MA, Ferkol T, Davis SD, Sagel SD, Dell SD, Rosenfeld M, Olivier KN, Milla C, Daniel SJ, Kimple AJ, Manion M, MR, Leigh MW, Genetic Disorders of Mucociliary Clearance Consortium.Diagnosis, monitoring, and treatment of primary ciliary dyskinesia: PCD foundation consensus recommendations based on state of the art review. 26418604 Pediatric pulmonology, 2016 Feb. : 51(2)115-32 PMCID:PMC4912005 - Seddon Cheifetz IM, J, Ranganathan SC, ATS/ERS Working Group on Infant and Young Children Pulmonary Function Testing.An Official American Thoracic Society/European Respiratory Society Workshop Report: Evaluation of Respiratory Mechanics and Function in the Pediatric and Neonatal Intensive Care Units. 26848609 Annals of the American Thoracic Society, 2016 Feb. : 13(2)S1-11 PMCID:PMC5461957 - Morgan WJ, DR, Pasta DJ, Foreman AJ, Wagener JS, Konstan MW, Scientific Advisory Group., Epidemiologic Study of Cystic Fibrosis.Forced Expiratory Volume in 1 Second Variability Helps Identify Patients with Cystic Fibrosis at Risk of Greater Loss of Lung Function. 26388208 The Journal of pediatrics, 2016 Feb. : 169116-21.e2 - Ruddy J, Emerson J, McNamara S, Genatossio A, Breuner C, Weber T, Rosenfeld MYoga as a Therapy for Adolescents and Young Adults With Cystic Fibrosis: A Pilot Study. 26665020 Global advances in health and medicine, 2015 Nov. : 4(6)32-6 PMCID:PMC4653591 - Sanders DB, Fink A, Mayer-Hamblett N, Sawicki GS, Rosenfeld WJEarly Life Growth Trajectories in Cystic Fibrosis are Associated with Pulmonary Function at Age 6 Years. 26340874 The Journal of pediatrics, 2015 Nov. : 167(5)1081-8.e1 PMCID:PMC5017309 - Mayer-Hamblett N, Kloster M, Rosenfeld M, Gibson RL, Retsch-Bogart GZ, Emerson J, Thompson V, Ramsey BWImpact of Sustained Eradication of New Pseudomonas aeruginosa Infection on Long-term Outcomes in Cystic Fibrosis. 25972024 Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015 Sep 1 : 61(5)707-15 PMCID:PMC4626753 - Rosenfeld M, VanDevanter DR, Ren CL, Elkin Pasta DJ, Konstan MW, Morgan WJ, Coordinators of the Epidemiologic Study of Cystic Fibrosis.Decline in lung function does not predict future decline in lung function in cystic fibrosis patients. 26086901 Pediatric pulmonology, 2015 Sept. : 50(9)856-62 - Sanders DB, Emerson J, Ren CL, Schechter MS, Gibson RL, Morgan W, Rosenfeld M, EPIC Study Group.Early Childhood Risk Factors for Decreased FEV1 at Age Six to Seven Years in Young Children with Cystic Fibrosis. 26288390 Annals of the American Thoracic Society, 2015 Aug. : 12(8)1170-6 PMCID:PMC4566413 - Cogen J, Emerson J, Sanders DB, Ren C, Schechter MS, Gibson RL, Morgan W, Rosenfeld M, EPIC Study Group.Risk factors for lung function decline in a large cohort of young cystic fibrosis patients. 26061914 Pediatric pulmonology, 2015 Carty CL, Chen WM, Cupples LA, DeStefano AL, Fornage M, Hardy J, Hsu L, Jackson RD, Jarvik GP, Kim DS, Lakshminarayan K, Lange LA, Manichaikul A, Quinlan AR, Singleton AB, Thornton TA, Nickerson DA, Peters U, Rich SS, National Heart, Lung, and Blood Institute Exome Sequencing Project.Rare and Coding Region Genetic Variants Associated With Stroke: The NHLBI PMCID:PMC4673986 - Subbarao P, Milla C, Aurora P, Davies JC, Davis SD, Hall GL, Heltshe S, Latzin P, Lindblad A, Pittman JE, Robinson PD, Rosenfeld M, Singer F, Starner TD, Ratjen F, Morgan WMultiple-Breath Washout as a Lung Function Test in Cystic Fibrosis. A Cystic Fibrosis Foundation Workshop Report. 26075554 Annals of the American Thoracic Society, 2015 June : 12(6)932-9 PMCID:PMC5466249 - Ren CL, Fink AK, Petren K, Borowitz DS, McColley SA, Sanders DB, Rosenfeld M, Marshall BCOutcomes of infants with indeterminate diagnosis detected by cystic fibrosis newborn screening. 25963008 Pediatrics, 2015 June : 135(6)e1386-92 - Alpern AN, Brumback LC, Ratjen F, Rosenfeld M, of the Parent Cystic Fibrosis Questionnaire--Revised (CFQ-R) infants and young children. 25443473 Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2015 May : 14(3)403-11 WE, Sawicki GS, Rasouliyan L, DR, Rosenfeld M, Pasta D, Morgan W, Konstan MWAntibiotic treatment of signs and symptoms of pulmonary exacerbations: a comparison by care site. 25530325 Pediatric pulmonology, 2015 May : 50(5)431-40 - Psoter KJ, De Roos AJ, Mayer JD, Kaufman JD, Wakefield J, Rosenfeld MFine particulate matter exposure and initial Pseudomonas aeruginosa acquisition in cystic fibrosis. 25594356 Annals of the Society, : 12(3)385-91 - Brumback LC, Baines A, Ratjen F, Davis SD, SL, AL, Rosenfeld M, ISIS Study Group.Pulmonary exacerbations and 24777957 Pediatric pulmonology, 2015 March R, Stitziel NO, Won HH, S, Kraus WE, Davies R, Nikpay M, Johansen CT, Wang J, Hegele RA, Hechter E, Marz W, Kleber ME, Huang J, Johnson AD, Li M, Burke GL, Gross M, Liu Y, Assimes TL, Heiss G, Lange EM, Folsom AR, Taylor HA, Olivieri O, Hamsten A, Clarke R, Reilly DF, Yin W, Rivas MA, Donnelly P, Rossouw JE, Psaty BM, Herrington DM, Wilson JG, Rich SS, Bamshad MJ, Tracy RP, Cupples LA, Rader DJ, Reilly Cresci J, Tang WH, Hazen SL, Allayee H, Reiner AP, Carlson CS, Kooperberg C, Jackson RD, Boerwinkle E, Lander ES, Schwartz SM, Siscovick DS, McPherson R, Tybjaerg-Hansen A, Abecasis GR, DA, Ardissino D, CJ, infarction. 25487149 Nature, 2015 Feb 5 : 518(7537)102-6 PMCID:PMC4319990 - Davis SD, Ferkol TW, Rosenfeld M, Lee HS, Dell SD, Sagel SD, Milla C, Zariwala MA, Pittman JE, Shapiro JL, JP, Hazucha MJ, Cooper ML, Knowles MR, ciliary dyskinesia by genotype and ultrastructural phenotype. 25493340 American journal of respiratory and critical care medicine, 2015 Feb 1 : 191(3)316-24 PMCID:PMC4351577 - Zemanick ET, Emerson J, Thompson V, McNamara S, Morgan W, Gibson RL, Rosenfeld M, EPIC Study Group.Clinical outcomes after initial pseudomonas acquisition in cystic fibrosis. 24644274 Pediatric pulmonology, 2015 Jan. : 50(1)42-8 - Mogayzel PJ Jr, Naureckas ET, Robinson KA, Brady C, Guill M, Lahiri T, Lubsch L, Matsui J, Oermann F, Rosenfeld M, RH, Hazle L, Sabadosa K, Marshall BC, Cystic Fibrosis Foundation Pulmonary Clinical Practice Guidelines Committee.Cystic Fibrosis Foundation pulmonary guideline. pharmacologic approaches to prevention and eradication of initial Pseudomonas aeruginosa infection. 25549030 Annals of the American Thoracic Society, 2014 Dec. : 11(10)1640-50 - Zemanick ET, Hoffman L, Rosenfeld MNarrowing in on early cystic fibrosis lung disease. 25398104 American journal of respiratory and critical care medicine, 2014 Nov 15 : 190(10)1082-4 - Shapiro AJ, Davis SD, Ferkol T, Dell SD, Rosenfeld M, Olivier KN, Sagel SD, C, Zariwala MA, Wolf JL, Hazucha MJ, Burns K, Robinson B, Knowles MR, Leigh MW, Genetic Disorders of Mucociliary Clearance Consortium.Laterality other than 24577564 Nov. : 146(5)1176-1186 PMCID:PMC4219335 - Shapiro AJ, Weck KE, Chao KC, Rosenfeld M, Nygren AO, Knowles MR, Leigh MW, Zariwala MACri du chat syndrome and primary ciliary dyskinesia: a common genetic cause on chromosome 5p. 25066065 The Journal of pediatrics, 2014 Oct. : 165(4)858-61 PMCID:PMC4177261 - Daines C, VanDeVanter D, Khan U, Emerson J, Heltshe S, McNamara S, Anstead M, Langkamp M, Doring G, Ratjen F, Ramsey B, Gibson RL, Morgan W, Rosenfeld M, EPIC Investigators.Serology as a diagnostic tool for predicting initialPseudomonas aeruginosa acquisition in children with cystic fibrosis. 25027419 Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2014 Sept. : 13(5)542-9 - Mayer-Hamblett N, Ramsey BW, Kulasekara HD, Wolter DJ, CE, Kulasekara BR, Armbruster CR, Burns JL, Retsch-Bogart G, Rosenfeld M, Gibson RL, Miller SI, Khan U, Hoffman LRPseudomonas aeruginosa phenotypes associated with eradication failure in children with cystic fibrosis. 24863401 Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014 Sep 1 : 59(5)624-31 PMCID:PMC4148602 - Tabor HK, Auer PL, Jamal SM, Yu JH, Gordon in exomes of 6,517 European and African Americans: implications for the return of incidental results. 25087612 American journal of human genetics, 2014 Aug 7 : 95(2)183-93 PMCID:PMC4129409 - Mayer-Hamblett N, Rosenfeld M, Gibson HD, Retsch-Bogart GZ, Morgan W, Wolter DJ, Pope CE, Houston LS, Kulasekara BR, Khan U, Burns JL, Miller SI, Hoffman LRPseudomonas aeruginosa in vitro phenotypes distinguish cystic fibrosis infection stages and outcomes. 24937177 American journal of respiratory and critical care medicine, 2014 Aug 1 : 190(3)289-97 PMCID:PMC4226041 - Ren CL, Konstan MW, Rosenfeld SJ, Morgan and Coordinators of the Epidemiologic Study of Cystic Fibrosis.Early childhood wheezing is associated with lower lung function in cystic fibrosis. 24123917 Pediatric pulmonology, 2014 Aug. Rosenfeld M, De Roos AJ, JD, Wakefield JDifferential geographical risk of initial Pseudomonas aeruginosa acquisition in young US children with cystic fibrosis. 24875373 American journal of epidemiology, 2014 Jun 15 : 179(12)1503-13 - Stanojevic S, Stocks J, Bountziouka V, Aurora P, Kirkby J, Bourke S, Carr SB, Gunn E, Prasad A, Rosenfeld M, Bilton DThe impact of switching to the new global lung function initiative equations on spirometry results in the UK CF registry. 24332996 Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2014 May : 13(3)319-27 - Gordon AS, Tabor HK, Johnson AD, Snively BM, Assimes TL, Auer PL, Ioannidis JP, Peters LE, Wang D, Sotoodehnia N, Rotter JI, Psaty BM, Jackson RD, Herrington drug-metabolism genes in a large-scale exome dataset. 24282029 Human molecular genetics, 2014 Apr 15 : 23(8)1957-63 PMCID:PMC3959810 - Knowles MR, Ostrowski LE, Leigh MW, Sears WE, Hazucha MJ, Carson JL, Olivier KN, Dell Milla CE, Randell SH, Yin W, Sannuti A, Metjian HM, Noone PG, Noone PJ, Olson CA, Patrone MV, Dang H, Lee HS, Hurd TW, Gee HY, Otto EA, Halbritter J, Kohl S, Kircher RSPH1 cause primary a unique clinical and ciliary phenotype. 24568568 American journal of respiratory and critical care medicine, 2014 Mar 15 : 189(6)707-17 PMCID:PMC3983840 - Simon TD, Mayer-Hamblett N, Whitlock KB, Kestle JR, Riva-Cambrin J, Rosenfeld M, Thorell EAFew Patient, Treatment, and Diagnostic or Microbiological Factors, Except Complications and Intermittent Negative Cerebrospinal Fluid (CSF) Cultures During First CSF Shunt Infection, Are Associated With Reinfection. 24567841 Journal of the Pediatric Infectious Diseases Society, 2014 March : 3(1)15-22 PMCID:PMC3933045 - Lange LA, Hu Y, Zhang H, Xue C, Schmidt EM, Tang ZZ, Bizon C, Lange EM, Smith JD, Turner EH, Jun G, Kang HM, Peloso G, Auer P, Li KP, Flannick J, Zhang J, Fuchsberger C, Gaulton K, Lindgren C, Locke A, Manning A, Sim X, Rivas MA, Holmen OL, Gottesman O, Lu Y, Ruderfer D, Stahl EA, Duan Q, Li Y, Durda P, Jiao S, Isaacs A, Hofman A, Bis JC, Correa A, Griswold ME, Jakobsdottir J, Smith AV, Schreiner PJ, Feitosa MF, Zhang Q, Huffman JE, Crosby J, Wassel CL, Do R, Franceschini N, LW, Robinson DN, Folsom AR, Lumley T, Fox ER, Carlson CS, Peters U, Jackson RD, van Duijn CM, Uitterlinden AG, Levy D, Rotter JI, Taylor HA, Gudnason V Jr, Siscovick DS, Fornage M, Borecki IB, S\u00c3\u00a6trom T, Ballantyne CM, Gabriel SB, O'Donnell CJ, LA, Kooperberg C, Wilson JG, Nickerson DA, Abecasis GR, Rich SS, low-frequency coding variants associated with LDL cholesterol. 24507775 American journal of human genetics, 2014 Feb 6 : 94(2)233-45 PMCID:PMC3928660 - Simon TD, Pope CE, Browd SR, Ojemann JG, Riva-Cambrin J, Mayer-Hamblett N, Rosenfeld Zerr DM, Hoffman LEvaluation of microbial bacterial and fungal diversity in cerebrospinal infection. data implicates SLC25A40 in hypertriglyceridemia. 24268658 American journal of human genetics, 2013 Dec 5 : 93(6)1035-45 PMCID:PMC3852929 - Austin-Tse C, Halbritter J, Zariwala MA, Gilberti Gee HY, Hellman N, Pathak N, Liu Y, Panizzi JR, Tritschler R, O'Toole E, Porath JD, Hurd TW, Chaki M, Diaz KA, Kohl S, Lovric S, Hwang DY, Braun DA, Schueler M, Airik R, Otto EA, Leigh MW, Noone PG, Carson JL, Davis SD, Pittman JE, Ferkol TW, Atkinson JJ, Olivier Sagel SD, Rosenfeld M, Milla Omran H, Porter Drummond IA, Hildebrandt FZebrafish Ciliopathy Screen Plus Human Mutational Analysis Identifies C21orf59 and CCDC65 Defects as Causing Primary Ciliary Dyskinesia. 24094744 American journal of human genetics, 2013 Oct 3 : 93(4)672-86 PMCID:PMC3791264 - - Presentations Title Event Location Date Early Pseudomonas Infection: Risk Factors and Outcomes North American Cystic Fibrosis Conference Indianapolis, IN 2017 The Promise and Challenge of Precision Medicine in Cystic Fibrosis and Beyond American Thoracic Society International Conference Washington DC 2017 Pediatric Lung Function Testing Across the Ages American Thoracic Society International Conference San Diego, CA 2017 The U.S. Approach to Preschool Airway Health Early CF Years Meeting Liverpool, UK 2016 Safety, Tolerability, and Pharmacodynamics of Combination Lumacaftor/Ivacaftor Therapy in Patients Aged 6-11 Yrs with CF Homozygous for the F508del-CFTR Mutation North American Cystic Fibrosis Conference Orlando, FL 2016 Lung Function Testing Across the Ages American Thoracic Society International Conference San Francisco, CA 2016 Clinical Trials in Infants and Young Children with CF: Where are we Heading? California CF Center Consortium Annual Conference Carmel, CA 2016 Detecting Early CF Lung Disease North American Cystic Fibrosis Conference Phoenix, AZ 2015 The CF Therapeutics Pipeline: Ushering in an Era of Great Hope Cystic Fibrosis Research Institute Redwood City, CA 2015 Results of the KIWI Trial of Ivacaftor in 2 to 5 Year Olds with CF and Gating Mutations European Cystic Fibrosis Conference Brussels, Belgium 2015 Early Lung Disease in CF - What Works? American Thoracic Society International Conference Denver, CO May 15, 2015 Research, a Straight Path Forward...or Not! American Thoracic Society International Society International Conference Denver, CO 2015 Cystic Fibrosis in Children American Thoracic Society International Conference Denver, CO 2015 Digital health monitoring: Beyond heart rates and pedometers Association for Women in Science 30th anniversary meeting Seattle, WA Feb 18, 2015 Home spirometry: whats on the horizon North American Cystic Fibrosis Conference Atlanta, GA Oct. 2014 Clinical trials in preschool children with CF European Cystic Fibrosis Conference Gothenburg, Sweden Jun 14, 2014 Survey of clinical infant lung function testing practices. International Symposium on Respiratory Disease Shanghai, China Nov 9, 2013 Early CF Lung Disease: Diagnosis, Treatment and Prevention Duke University School of Medicine Nov 28, 2012 Pulmonary Exacerbation as a Clinical Trial Endpoint: The Pros and Cons North American CF Conference Orlando, FL Oct. 2012 Designing Investigator Initiated Trials Presentation In symposium \"Multidisciplinary Approach to Investigator-initiated Trials,\" North American CF Conference Orlando, FL Oct. 2012 Pulmonary and Nutritional Consequences of CF in the First 6 Years of Life presentation in symposium \"After the Newborn Screen: What to Do Next?\" North American CF Conference Orlando, FL Oct. 2012 What lung function test is best for managing young children with CF talk in session \"Is it time to bring pre-school lung function testing to the clinic? Update from the ATS/ERS Task Force\" European Respiratory Society Congress Vienna, Austria Sept. 2012 Writing Your First Grant ITHS career development series, University of Washington Seattle, WA Oct 30, 2009 Successful Transition to an Academic Career half-day SCH Fellows' College workshop unknown Oct 28, 2009 Risk factors for early age at acquisition of Pseudomonas aeruginosa North American Cystic Fibrosis Conference Minneapolis, MN Oct 17, 2009 Newborn screening North American Cystic Fibrosis Conference Minneapolis, MN Oct 17, 2009 Pulmonary Exacerbations: How do we define them Symposium presentation, North American Cystic Fibrosis Conference Minneapolis, MN Oct 16, 2009 Comparison of published pulmonary exacerbation definitions Cystic Fibrosis Foundation Workshop on Pulmonary Exacerbations Bethesda, MD Sep 9, 2009 Guidelines for Care of theGuidelines for Care of the Infant with CF Infant with CF Cystic Fibrosis annual Northwest regional conference, Center for Urban Horticulture unknown Jul 24, 2009 Risk factors for early Pseudomonas acquisition Cystic Fibrosis Epidemiology/Biostatistics Working Group annual meeting, Center for Urban Horticulture unknown Jul 23, 2009 Optimal lung function tests for monitoring cystic fibrosis, bronchopulmonary dysplasia and recurrernt wheezing in children under 6 years of age American Thoracic Society annual convention San Diego, CA May 12, 2009 unknown ITHS Career Development Seminar- Career Development (K Award) Seminar unknown Jan 29, 2009 Overview - Board Certification(s) - Pediatric Pulmonology - Medical/Professional School - Harvard Medical School, Boston, MA University of Washington, Seattle, WA - Clinical Interests - Diagnosis and management of all pediatric lung conditions - Research Description - Multicenter observational studies and investigator-initiated clinical trials in cystic fibrosis emphasizing early CF lung disease. Multicenter observational studies in primary ciliary dyskinesia. Mobile health applications and remote monitoring, including home spirometry. Development of outcome measures for clinical trials, including home spirometry, home cough monitoring, infant and preschool lung function tests. Global health, including mobile health tools for diagnosis of respiratory distress and pneumonia in low resource settings. - Research Focus Area - Translational research, observational studies, investigator-initiated interventional studies, Therapeutic Trials "}